Science
Acadia Pharmaceuticals Inc (NASDAQ:ACAD) Has Made The 41.61% Recovery, Could Gain Another 9.89% Ahead
In recent trading session, Acadia Pharmaceuticals Inc (NASDAQ:ACAD) saw 10.34 million shares changing hands at last check today with its beta currently measuring 0.54. Company’s
